The QIAstat-Dx Respiratory SARS-CoV-2 Panel is a multiplexed nucleic acid real-time PCR test intended for the qualitative detection and differentiation of nucleic acid from multiple respiratory viral and bacterial organisms, including the SARS-CoV-2 virus, in nasopharyngeal swabs (NPS) eluted in universal transport media collected from individuals suspected of COVID-19 by their healthcare provider

  • Enables detection of the SARS-CoV-2 virus that causes COVID-19, in addition to 20 other respiratory targets 
  • Intuitive workflow with less than one-minute hands-on time 
  • All wet and dry reagents onboard and room temperature stable 
  • Comprehensive qualitative results available in about an hour

The QIAstat-Dx Respiratory SARS-CoV-2 Panel is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy the QIAstat-Dx Respiratory SARS-CoV-2 Panel for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the QIAstat-Dx Respiratory SARS-CoV-2 Panel for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the QIAstat-Dx Respiratory SARS-CoV-2 Panel or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top